Germany – Medical aids – Bekanntmachung eines Vertragsabschlusses nach § 127 Abs. 1 SGB V: Versorgung mit Hilfsmitteln der PG 19/50 (Krankenpflegeartikel)

Health · Germany government procurement

This opportunity is now closed. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

Germany – Medical aids – Notification of a contract conclusion pursuant to Section 127 Paragraph 1 of the German Social Code, Book V (SGB V): Supply of aids of the PG 19/50 (medical supplies)

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyHealth
CountryGermany
CategoryHealth Services
PublishedAugust 27, 2025
Procurement stageActive solicitation
ClosedClosing date not published
StatusClosed — no longer accepting responses
Original languageGerman — members read it in their own language
Official sourceView original notice
Last verifiedOctober 11, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Browse Similar Open Opportunities in Germany

Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu Wirkstoffen aus dem-87.VV
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V zu Lösungen zur parenteralen Ernährung Kombinationen (ATC-Code: B05BA10).
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff Adalimumab
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff Abirateron in der Wirkstärke 500mg und der Packungsgröße 90St.
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff Epoetin zeta
Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) in the period from May 1, 2025 to December 31, 2026
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu dem Wirkstoff Evolocumab - VV83
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V ab dem 01.08.2025 / 01.10.2025

See every Germany Health Services opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Health Services intelligence report in your inbox

A personalized report on Germany Health Services opportunities, emailed in 5-10 minutes. One per month, no account needed.